Matches in Wikidata for { <http://www.wikidata.org/entity/Q96815462> ?p ?o ?g. }
- Q96815462 description "2020 nî lūn-bûn" @default.
- Q96815462 description "2020年の論文" @default.
- Q96815462 description "2020年学术文章" @default.
- Q96815462 description "2020年学术文章" @default.
- Q96815462 description "2020年学术文章" @default.
- Q96815462 description "2020年学术文章" @default.
- Q96815462 description "2020年学术文章" @default.
- Q96815462 description "2020年学术文章" @default.
- Q96815462 description "2020年學術文章" @default.
- Q96815462 description "2020年學術文章" @default.
- Q96815462 description "2020年學術文章" @default.
- Q96815462 description "2020年學術文章" @default.
- Q96815462 description "2020年學術文章" @default.
- Q96815462 description "2020년 논문" @default.
- Q96815462 description "article científic" @default.
- Q96815462 description "article scientific" @default.
- Q96815462 description "article scientifique" @default.
- Q96815462 description "articol științific" @default.
- Q96815462 description "articolo scientifico" @default.
- Q96815462 description "artigo científico" @default.
- Q96815462 description "artigo científico" @default.
- Q96815462 description "artigo científico" @default.
- Q96815462 description "artikel ilmiah" @default.
- Q96815462 description "artikull shkencor" @default.
- Q96815462 description "artikulong pang-agham" @default.
- Q96815462 description "artykuł naukowy" @default.
- Q96815462 description "artículo científico publicado en 2020" @default.
- Q96815462 description "artículu científicu" @default.
- Q96815462 description "bilimsel makale" @default.
- Q96815462 description "bài báo khoa học" @default.
- Q96815462 description "naučni članak" @default.
- Q96815462 description "scienca artikolo" @default.
- Q96815462 description "scientific article published on 30 June 2020" @default.
- Q96815462 description "scientific article published on 30 June 2020" @default.
- Q96815462 description "scientific article published on 30 June 2020" @default.
- Q96815462 description "teaduslik artikkel" @default.
- Q96815462 description "tieteellinen artikkeli" @default.
- Q96815462 description "tudományos cikk" @default.
- Q96815462 description "vedecký článok" @default.
- Q96815462 description "vetenskaplig artikel" @default.
- Q96815462 description "videnskabelig artikel udgivet 30. juni 2020" @default.
- Q96815462 description "vitenskapelig artikkel" @default.
- Q96815462 description "vitskapeleg artikkel" @default.
- Q96815462 description "vědecký článek" @default.
- Q96815462 description "wetenschappelijk artikel" @default.
- Q96815462 description "wissenschaftlicher Artikel" @default.
- Q96815462 description "επιστημονικό άρθρο" @default.
- Q96815462 description "мақолаи илмӣ" @default.
- Q96815462 description "наукова стаття, опублікована в червні 2020" @default.
- Q96815462 description "научна статия" @default.
- Q96815462 description "научная статья" @default.
- Q96815462 description "научни чланак" @default.
- Q96815462 description "научни чланак" @default.
- Q96815462 description "מאמר מדעי" @default.
- Q96815462 description "مقالة علمية نشرت في 30 يونيو 2020" @default.
- Q96815462 description "৩০ জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q96815462 description "บทความทางวิทยาศาสตร์" @default.
- Q96815462 description "სამეცნიერო სტატია" @default.
- Q96815462 name "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)" @default.
- Q96815462 name "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)" @default.
- Q96815462 type Item @default.
- Q96815462 label "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)" @default.
- Q96815462 label "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)" @default.
- Q96815462 prefLabel "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)" @default.
- Q96815462 prefLabel "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)" @default.
- Q96815462 P1433 Q96815462-37598881-8360-4B27-9960-D6DC9054F685 @default.
- Q96815462 P1476 Q96815462-BB504D18-F408-4906-AD1B-39192B824876 @default.
- Q96815462 P2093 Q96815462-09758A6F-200B-442B-9B14-2BCAD432E233 @default.
- Q96815462 P2093 Q96815462-162559D7-E166-46D2-A65A-5598EA7BA698 @default.
- Q96815462 P2093 Q96815462-1EC79197-C40A-47E6-9AEB-E140702C2BFB @default.
- Q96815462 P2093 Q96815462-49777590-9C98-4F17-82BA-307134826EA3 @default.
- Q96815462 P2093 Q96815462-52ECBE94-7535-498A-87E4-6008E8A2FACC @default.
- Q96815462 P2093 Q96815462-560584B5-A025-44BF-9CBF-CD0F8076C011 @default.
- Q96815462 P2093 Q96815462-71570F4F-1614-4748-BA7C-9BA12A18F02A @default.
- Q96815462 P2093 Q96815462-75E156C9-A67F-499A-9159-6A71E238E659 @default.
- Q96815462 P2093 Q96815462-7E535628-3148-47D4-84C4-BD5112C965D0 @default.
- Q96815462 P2093 Q96815462-842728B5-A137-44D2-86A7-10F10B017152 @default.
- Q96815462 P2093 Q96815462-85068D81-E886-4119-BE8B-42577BC9A6ED @default.
- Q96815462 P2093 Q96815462-8771CEBB-2AE3-4928-A33A-4828A7169774 @default.
- Q96815462 P2093 Q96815462-8BA7633B-FD80-4E7F-92FB-DDF1BB1BF8FD @default.
- Q96815462 P2093 Q96815462-98C4080B-E90F-496E-9C7B-DA0459411DD7 @default.
- Q96815462 P2093 Q96815462-AA3DEAEA-3915-4F19-BE97-DBC902B909C8 @default.
- Q96815462 P2093 Q96815462-DCD9057A-38CF-4A07-8FD0-64A5C62A9F02 @default.
- Q96815462 P2093 Q96815462-EE54F7FF-94B5-4649-AB2F-AFC478F2E8CA @default.
- Q96815462 P2093 Q96815462-EF875987-B698-4423-BB36-D57FFDE807EA @default.
- Q96815462 P31 Q96815462-806DA9E0-15CE-4F41-AFBB-0CF2E9D26199 @default.
- Q96815462 P356 Q96815462-73E2DCB6-B671-4131-B08A-9D3434EB8F96 @default.
- Q96815462 P577 Q96815462-4EA29955-4F0F-4940-99E8-DA99ACD0AFA7 @default.
- Q96815462 P698 Q96815462-2A8399A7-AAA4-4D6C-97FE-2C4BC2B68C42 @default.
- Q96815462 P921 Q96815462-665BA83F-E501-49E8-9129-590BC48E2C24 @default.
- Q96815462 P921 Q96815462-EE852D0C-B135-4ECD-8E95-1D37F5DBFB99 @default.
- Q96815462 P356 IJGC-2020-001572 @default.
- Q96815462 P698 32606097 @default.
- Q96815462 P1433 Q15749181 @default.
- Q96815462 P1476 "Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)" @default.
- Q96815462 P2093 "Alexander Burges" @default.
- Q96815462 P2093 "Alexander Reuss" @default.
- Q96815462 P2093 "Andres Redondo" @default.
- Q96815462 P2093 "Christian Kurzeder" @default.
- Q96815462 P2093 "Domenica Lorusso" @default.